46 Drug-Drug Interactions: Saxagliptin is a strong CYP3A4 inhibitor, so its labeling recommends limiting saxagliptin to 2.5 mg daily in patients taking other strong CYP3A4 inhibitors, such as ketoconazole, based on the risk of increased saxagliptin levels
For the best results, leave it to the pros
Ongoing Trials Several large-scale trials are currently evaluating Retatrutides effectiveness: TRIUMPH-3 Trial Focus: Obesity + Cardiovascular Disease Goal: Weight loss + cardiovascular outcomes TRANSCEND-T2D-12 Trial Focus: Type 2 Diabetes Goal: Glycemic control + safety in diabetic populations These trials are helping researchers assess Retatrutides impact beyond weight lossespecially its role in preventing heart disease and improving diabetes management
Wegovy comes as a pre-filled, single-use injection pen that must be stored correctly to preserve the medication's stability
I am struggling with constipation after starting my GLP-1
however, unmeasured confounders, including behavioral, metabolic, or pharmacologic factors, may also contribute to these associations
